Shared decision making in IBD: A novel approach to trial consent and timing

Christine L Schuler, Cassandra Dodds, Kevin A Hommel, Richard F Ittenbach, Lee A Denson, Ellen A Lipstein, Christine L Schuler, Cassandra Dodds, Kevin A Hommel, Richard F Ittenbach, Lee A Denson, Ellen A Lipstein

Abstract

Background: Shared decision making (SDM) between families and physicians may facilitate informed, timely decisions to proceed with biologic therapy in children with inflammatory bowel disease (IBD). Our team previously developed an SDM tool to aid communication between physicians and families when considering biologic therapy for children with IBD.

Objective: We are conducting a prospective, pre-post pilot trial of a new SDM tool. The primary aim of the study is to assess feasibility of both the intervention and trial procedures for a future large-scale trial.

Methods: We are enrolling physicians with experience prescribing biologic therapy in the past year and families of children with IBD. Families in the intervention arm receive a 3-step intervention including a letter sent before trial consent or clinic appointment, an in-clinic decision tool and a follow-up phone call. Our primary trial outcome is a measure of feasibility, with measures of clinical and decision outcomes secondary. We seek to enroll 27 families in each of 2 arms (usual-care and intervention) and plan data collection at the time of the initial visit or hospital stay, and at 1 week, 3 months, and 6 months after the initial visit.

Conclusion: This study protocol is designed to demonstrate that integrating novel consent procedures, including timing and multiple versions of written consent, may increase trial feasibility while maintaining scientific rigor and full protection of study participants.

Keywords: Consent; Inflammatory bowel disease; Pediatrics; Pilot trials.

Figures

Fig. 1
Fig. 1
Timing of interventions and follow-up for data collection.
Fig. 2
Fig. 2
IBD treatment option cards.

References

    1. Knapp C., Huang I.C., Madden V., Vadaparampil S., Quinn G., Shenkman E. An evaluation of two decision-making scales for children with life-limiting illnesses. Palliat. Med. 2009;23(6):518–525. PubMed PMID: 19346274.
    1. Lipstein E.A., Lovell D.J., Denson L.A., Kim S.C., Spencer C., Ittenbach R.F., Britto M.T. High levels of decisional conflict and decision regret when making decisions about biologics. J. Pediatr. Gastroenterol. Nutr. 2016;63(6):e176–e181. Epub 2016/10/18. PubMed PMID: 27749390; PMCID: PMC5123667.
    1. Hoentjen F., van Bodegraven A.A. Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease. World J. Gastroenterol. 2009;15(17):2067–2073. Epub 2009/05/07. PubMed PMID: 19418577; PMCID: 2678575.
    1. Brown S.L., Greene M.H., Gershon S.K., Edwards E.T., Braun M.M. Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration. Arthritis Rheum. 2002;46(12):3151–3158. Epub 2002/12/17. PubMed PMID: 12483718.
    1. Diak P., Siegel J., La Grenade L., Choi L., Lemery S., McMahon A. Tumor necrosis factor alpha blockers and malignancy in children: forty-eight cases reported to the Food and Drug Administration. Arthritis Rheum. 2010;62(8):2517–2524. Epub 2010/05/28. PubMed PMID: 20506368.
    1. Dulai P.S., Thompson K.D., Blunt H.B., Dubinsky M.C., Siegel C.A. Risks of serious infection or lymphoma with anti–tumor necrosis factor therapy for pediatric inflammatory bowel disease: a systematic review. Clin. Gastroenterol. Hepatol. 2014;12(9):1443–1451.
    1. Walters T.D., Kim M.O., Denson L.A., Griffiths A.M., Dubinsky M., Markowitz J., Baldassano R., Crandall W., Rosh J., Pfefferkorn M., Otley A., Heyman M.B., LeLeiko N., Baker S., Guthery S.L., Evans J., Ziring D., Kellermayer R., Stephens M., Mack D., Oliva-Hemker M., Patel A.S., Kirschner B., Moulton D., Cohen S., Kim S., Liu C., Essers J., Kugathasan S., Hyams J.S., Group P.-K.R. Increased effectiveness of early therapy with anti-tumor necrosis factor-alpha vs an immunomodulator in children with Crohn's disease. Gastroenterology. 2014;146(2):383–391. PubMed PMID: 24162032.
    1. Forrest C.B., Crandall W.V., Bailey L.C., Zhang P., Joffe M.M., Colletti R.B., Adler J., Baron H.I., Berman J., del Rosario F. Effectiveness of anti-TNFα for Crohn disease: research in a pediatric learning health system. Pediatrics. 2014;134(1):37–44. PubMed PMID: 24935993.
    1. Kugathasan S., Denson L.A., Walters T.D., Kim M.O., Marigorta U.M., Schirmer M., Mondal K., Liu C., Griffiths A., Noe J.D., Crandall W.V., Snapper S., Rabizadeh S., Rosh J.R., Shapiro J.M., Guthery S., Mack D.R., Kellermayer R., Kappelman M.D., Steiner S., Moulton D.E., Keljo D., Cohen S., Oliva-Hemker M., Heyman M.B., Otley A.R., Baker S.S., Evans J.S., Kirschner B.S., Patel A.S., Ziring D., Trapnell B.C., Sylvester F.A., Stephens M.C., Baldassano R.N., Markowitz J.F., Cho J., Xavier R.J., Huttenhower C., Aronow B.J., Gibson G., Hyams J.S., Dubinsky M.C. Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study. Lancet. 2017;389(10080):1710–1718. Epub 2017/03/06. PubMed PMID: 28259484; PMCID: PMC5719489.
    1. Shay L.A., Lafata J.E. Where is the evidence? A systematic review of shared decision making and patient outcomes. Med. Decis. Mak. 2015;35(1):114–131. PubMed PMID: 25351843; PMCID: 4270851.
    1. Stacey D., Legare F., Lewis K., Barry M.J., Bennett C.L., Eden K.B., Holmes-Rovner M., Llewellyn-Thomas H., Lyddiatt A., Thomson R., Trevena L. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst. Rev. 2017;4(4) Epub 2017/04/13. PubMed PMID: 28402085.
    1. Lipstein E.A., Britto M.T. Evolution of pediatric chronic disease treatment decisions: a qualitative, longitudinal view of parents' decision-making process. Med. Decis. Mak. 2015;35(6):703–713. Epub 2015/04/23. PubMed PMID: 25899248; PMCID: PMC4618270.
    1. Lipstein E.A., Lovell D.J., Denson L.A., Moser D.W., Saeed S.A., Dodds C.M., Britto M.T. Parents' information needs in tumor necrosis factor-alpha inhibitor treatment decisions. J. Pediatr. Gastroenterol. Nutr. 2013;56(3):244–250. Epub 2012/10/13. PubMed PMID: 23059648.
    1. Lipstein E.A., Lovell D.J., Denson L.A., Kim S.C., Spencer C., Britto M.T. Parents’ information needs and influential factors when making decisions about TNF-alpha inhibitors. Pediatr Rheumatol Online J. 2016;14(1) PMID: PMC5024421.
    1. Lipstein E.A., Dodds C.M., Britto M.T. Real life clinic visits do not match the ideals of shared decision making. J. Pediatr. 2014;165(1):178–183 e1. PubMed PMID: 24795203; PMCID: PMC4106460.
    1. Brinkman W.B., Lipstein E.A., Taylor J., Schoettker P.J., Naylor K., Jones K., Vora S.S., Mims C.C., Roth-Wojcicki E., Gottlieb B., Griffin N., Lannon C., Morgan E. Design and implementation of a decision aid for juvenile idiopathic arthritis medication choices. Pediatr. Rheumatol. Online J. 2017;15(1):48. PubMed PMID: 28583183.
    1. Breslin M., Mullan R.J., Montori V.M. The design of a decision aid about diabetes medications for use during the consultation with patients with type 2 diabetes. Patient Educ. Couns. 2008;73(3):465–472. Epub 2008/09/06. PubMed PMID: 18771876.
    1. Mullan R.J., Montori V.M., Shah N.D., Christianson T.J., Bryant S.C., Guyatt G.H., Perestelo-Perez L.I., Stroebel R.J., Yawn B.P., Yapuncich V., Breslin M.A., Pencille L., Smith S.A. The diabetes mellitus medication choice decision aid: a randomized trial. Arch. Intern. Med. 2009;169(17):1560–1568. PubMed PMID: 19786674.
    1. Brinkman W.B., Hartl Majcher J., Poling L.M., Shi G., Zender M., Sucharew H., Britto M.T., Epstein J.N. Shared decision-making to improve attention-deficit hyperactivity disorder care. Patient Educ. Couns. 2013;93(1):95–101. PubMed PMID: 23669153; PMCID: 3759588.
    1. Lipstein E.A., Dodds C.M., Lovell D.J., Denson L.A., Britto M.T. Making decisions about chronic disease treatment: a comparison of parents and their adolescent children. Health Expect. 2016;19(3):716–726. Epub 2014/06/04. PubMed PMID: 24889468; PMCID: PMC5055230.
    1. Dodds C.M., Britto M.T., Denson L.A., Lovell D.J., Saeed S., Lipstein E.A. Physicians' perceptions of shared decision making in chronic disease and its barriers and facilitators. J. Pediatr. 2016;171:307–309. Epub 2016/01/29. PubMed PMID: 26817588; PMCID: PMC4808590.
    1. Lipstein E.A., Muething K.A., Dodds C.M., Britto M.T. "I'm the one taking it": adolescent participation in chronic disease treatment decisions. J. Adolesc. Health. 2013;53(2):253–259. Epub 2013/04/09. PubMed PMID: 23561895.
    1. Carroll S.L., McGillion M., Stacey D., Healey J.S., Browne G., Arthur H.M., Thabane L. Development and feasibility testing of decision support for patients who are candidates for a prophylactic implantable defibrillator: a study protocol for a pilot randomized controlled trial. Trials. 2013;14:346. Epub 2013/10/24. PubMed PMID: 24148851; PMCID: PMC4015905.
    1. Weymiller A.J., Montori V.M., Jones L.A., Gafni A., Guyatt G.H., Bryant S.C., Christianson T.J., Mullan R.J., Smith S.A. Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial. Arch. Intern. Med. 2007;167(10):1076–1082. PubMed PMID: 17533211.
    1. Turner D., Otley A.R., Mack D., Hyams J., de Bruijne J., Uusoue K., Walters T.D., Zachos M., Mamula P., Beaton D.E., Steinhart A.H., Griffiths A.M. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology. 2007;133(2):423–432. PubMed PMID: 17681163.
    1. Shepanski M.A., Markowitz J.E., Mamula P., Hurd L.B., Baldassano R.N. Is an abbreviated pediatric crohn's disease activity index better than the original? J. Pediatr. Gastroenterol. Nutr. 2004;39(1):68–72. PubMed PMID: 15187784.
    1. Otley A., Loonen H., Parekh N., Corey M., Sherman P.M., Griffiths A.M.J.G. Assessing Activity of Pediatric Crohn's Disease: Which Index to Use? vol. 116. 1999. pp. 527–531. 3.
    1. Hyams J., Crandall W., Kugathasan S., Griffiths A., Olson A., Johanns J., Liu G., Travers S., Heuschkel R., Markowitz J., Cohen S., Winter H., Veereman-Wauters G., Ferry G., Baldassano R., Group R.S. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children. Gastroenterology. 2007;132(3):863–873. quiz 1165-6. PubMed PMID: 17324398.
    1. Kim M.J., Lee J.S., Lee J.H., Kim J.Y., Choe Y.H. Infliximab therapy in children with Crohn's disease: a one-year evaluation of efficacy comparing 'top-down' and 'step-up' strategies. Acta Paediatr. 2010 Epub 2010/07/16. PubMed PMID: 20626362.
    1. Steiner J.F., Koepsell T.D., Fihn S.D., Inui T.S. A general method of compliance assessment using centralized pharmacy records. Description and validation. Med. Care. 1988;26(8):814–823. PubMed PMID: 3398608.
    1. Varni J.W., Seid M., Kurtin P.S. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med. Care. 2001;39(8):800–812. PubMed PMID: 11468499.
    1. O'Connor A.M. Validation of a decisional conflict scale. Med. Decis. Mak. 1995;15(1):25–30. Epub 1995/01/01. PubMed PMID: 7898294.
    1. Brehaut J.C., O'Connor A.M., Wood T.J., Hack T.F., Siminoff L., Gordon E., Feldman-Stewart D. Validation of a decision regret scale. Med. Decis. Mak. 2003;23(4):281–292. Epub 2003/08/21. PubMed PMID: 12926578.
    1. Barr P.J., O'Malley A.J., Tsulukidze M., Gionfriddo M.R., Montori V., Elwyn G. The psychometric properties of Observer OPTION(5), an observer measure of shared decision making. Patient Educ. Couns. 2015;98(8):970–976. PubMed PMID: 25956069.
    1. Elwyn G., Edwards A., Wensing M., Hood K., Atwell C., Grol R. Shared decision making: developing the OPTION scale for measuring patient involvement. Qual. Saf. Health Care. 2003;12(2):93–99. Epub 2003/04/08. PubMed PMID: 12679504; PMCID: 1743691.
    1. Kriston L., Scholl I., Holzel L., Simon D., Loh A., Harter M. The 9-item Shared Decision Making Questionnaire (SDM-Q-9). Development and psychometric properties in a primary care sample. Patient Educ. Couns. 2010;80(1):94–99. Epub 2009/11/03. doi: S0738-3991(09)00450-9 [pii] 10.1016/j.pec.2009.09.034. PubMed PMID: 19879711.
    1. Lipstein E.A., Lovell D.J., Denson L.A., Kim S.C., Spencer C., Britto M.T. Parents' information needs and influential factors when making decisions about TNF-alpha inhibitors. Pediatr. Rheumatol. Online J. 2016;14(1):53. PubMed PMID: 27641835; PMCID: PMC5024421.
    1. Montori V.M., Gafni A., Charles C. A shared treatment decision-making approach between patients with chronic conditions and their clinicians: the case of diabetes. Health Expect. 2006;9(1):25–36. Epub 2006/01/27. PubMed PMID: 16436159.
    1. Wyatt K.D., List B., Brinkman W.B., Prutsky Lopez G., Asi N., Erwin P., Wang Z., Domecq Garces J.P., Montori V.M., LeBlanc A. Shared decision making in pediatrics: a systematic review and meta-analysis. Acad. Pediatr. 2015;15(6):573–583. Epub 2015/05/20. PubMed PMID: 25983006.
    1. Lipstein E.A., Brinkman W.B., Fiks A.G., Hendrix K.S., Kryworuchko J., Miller V.A., Prosser L.A., Ungar W.J., Fox D. An emerging field of research: challenges in pediatric decision making. Med. Decis. Mak. 2015;35(3):403–408. Epub 2014/08/26. PubMed PMID: 25145576; PMCID: PMC4336633.
    1. Kistin C., Silverstein M. Pilot studies: a critical but potentially misused component of interventional research. J. Am. Med. Assoc. 2015;314(15):1561–1562. PubMed PMID: 26501530.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa